Cyclosporine/Azole Antifungal Agents
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
The cause of this interaction is not known. Antifungal medicines may change the way your body processes cyclosporine.
What might happen:
Your blood levels of cyclosporine may increase and cause toxic effects that may harm your kidneys.
What you should do about this interaction:
Make sure that your doctor knows all of the medicines that you are taking.Tell your doctor if you have any kidney problems. If you experience any shortness of breath, unusual swelling, changes in the color or amount of your urine, or changes in how often you urinate, contact your doctor. Your cyclosporine blood levels may need to be checked and the dosage adjusted when you first start or stop taking the antifungal medicine.Your healthcare professionals (e.g. doctor or pharmacist) may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Ferguson RM, Sutherland DE, Simmons RL, Najarian JS. Ketoconazole, cyclosporin metabolism, and renal transplantation. Lancet 1982 Oct 16; 2(8303):882-3.
2.Daneshmend TK. Ketoconazole-cyclosporin interaction. Lancet 1982 Dec 11; 2(8311):1342-3.
3.Smith JM, Hows JM, Gordon-Smith EC, Baughan A, Goldman JM. Interaction of CyA and ketoconazole. Clin Sci 1983;64(2):67P.
4.Shepard JH, Canafax DM, Simmons RL, Najarian JS. Cyclosporine-ketoconazole: a potentially dangerous drug-drug interaction. Clin Pharm 1986 Jun;5(6):468.
5.Kwan JT, Foxall PJ, Davidson DG, Bending MR, Eisinger AJ. Interaction of cyclosporin and itraconazole. Lancet 1987 Aug 1;2(8553):282.
6.Novakova I, Donnelly P, de Witte T, de Pauw B, Boezeman J, Veltman G. Itraconazole and cyclosporin nephrotoxicity. Lancet 1987 Oct 17; 2(8564):920-1.
7.Trenk D, Brett W, Jahnchen E, Birnbaum D. Time course of cyclosporin/itraconazole interaction. Lancet 1987 Dec 5;2(8571):1335-6.
8.Daneshmend TK, Warnock DW. Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet 1988 Jan;14(1):13-34.
9.Sugar AM, Saunders C, Idelson BA, Bernard DB. Interaction of fluconazole and cyclosporine. Ann Intern Med 1989 May 15;110(10):844.
10.Collignon P, Hurley B, Mitchell D. Interaction of fluconazole with cyclosporin. Lancet 1989 Jun 3;1(8649):1262.
11.Charles BG, Ravenscroft PJ, Rigby RJ. The ketoconazole-cyclosporin interaction in an elderly renal transplant patient. Aust N Z J Med 1989 Jun;19(3):292-3.
12.Baciewicz AM, Baciewicz FA Jr. Cyclosporine pharmacokinetic drug interactions. Am J Surg 1989 Feb;157(2):264-71.
13.First MR, Schroeder TJ, Weiskittel P, Myre SA, Alexander JW, Pesce AJ. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. Lancet 1989 Nov 18;2(8673):1198-201.
14.Frey FJ. Concomitant cyclosporin and ketoconazole. Lancet 1990 Jan 13; 335(8681):109-10.
15.Ah-Sing E, Poole TW, Ioannides C, King LJ. Mechanism of the ketoconazole-cyclosporin interaction. Arch Toxicol 1990;64(6):511-3.
16.Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990 Mar-Apr;12 Suppl 3:S327-33.
17.Katzir D, Balschke TF. The cyclosporine-ketoconazole interaction. Hosp Ther 1990 Jan;15:99-112.
18.First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittel P, Myre SA, Pesce AJ. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 1991 Feb;51(2):365-70.
19.Canafax DM, Graves NM, Hilligoss DM, Carleton BC, Gardner MJ, Matas AJ. Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double- blind, randomized pharmacokinetic and safety study. Transplant Proc 1991 Feb; 23(1 Pt 2):1041-2.
20.Albengres E, Tillement JP. Cyclosporin and ketoconazole, drug interaction or therapeutic association?. Int J Clin Pharmacol Ther Toxicol 1992 Dec; 30(12):555-70.
21.Lopez-Gil JA. Fluconazole-cyclosporine interaction: a dose-dependent effect?. Ann Pharmacother 1993 Apr;27(4):427-30.
22.First MR, Schroeder TJ, Michael A, Hariharan S, Weiskittel P, Alexander JW. Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial. Transplantation 1993 May; 55(5):1000-4.
23.Vfend (voriconazole) US prescribing information. Pfizer Inc. November, 2011.
24.Romero AJ, Pogamp PL, Nilsson LG, Wood N. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients. Clin Pharmacol Ther 2002 Apr;71(4):226-34.
25.Noxafil (posaconazole) UK summary of product characteristics. Schering-Plough Ltd. February 2, 2006.
26.Noxafil (posaconazole) US prescribing information. Schering Corporation June, 2012.
27.Sansone-Parsons A, Krishna G, Martinho M, Kantesaria B, Gelone S, Mant TG. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus. Pharmacotherapy 2007 Jun;27(6):825-34.